Indocid Retard 75 mg

Indocid Retard is a well-established pharmaceutical product containing the active ingredient indomethacin. Originally developed by the American pharmaceutical giant Merck & Co. (known as MSD outside the U.S. and Canada), the brand was part of a major divestment strategy where Merck sold various non-core legacy products to specialty pharmaceutical companies.

In Europe, the rights to Indocid were acquired by Aspen Pharmacare, while H.A.C. Pharma serves as a key distributor and marketing authorization holder in specific regions such as France and Portugal. Manufacturing of Indocid takes place across a global network of facilities, often utilizing third-party contract manufacturing organizations in countries like Germany or the United Kingdom. Ownership now rests with Aspen Pharmacare, a South African multinational specialty pharmaceutical group that focuses on high-quality, generic, and branded medicines.